Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-read sequencing maps transposable element variation and its regulatory and epigenetic effects in the human brain.

bioRxiv : the preprint server for biology·2026
Same author

iPSC Neurodegenerative Disease Initiative isogenic CAG repeat iPSC line for Huntington's disease.

bioRxiv : the preprint server for biology·2026
Same author

Variable mitochondrial phenotypes and reduced complex IV assembly factor SCO2 in LRRK2-G2019S fibroblasts.

Scientific reports·2026
Same author

Haplotype-resolved DNA methylation at the <i>APOE</i> locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease risk.

NPJ dementia·2026
Same author

Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank study.

Brain : a journal of neurology·2026
Same author

Region-specific transcriptional signatures of brain aging in the absence of neuropathology at the single-cell level.

npj aging·2026

Related Experiment Video

Updated: Jun 13, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Parkinson's disease: insights from pathways.

Mark R Cookson1, Oliver Bandmann

  • 1National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. cookson@mail.nih.gov

Human Molecular Genetics
|April 28, 2010
PubMed
Summary
This summary is machine-generated.

Understanding genetic mutations in Parkinson's disease (PD) reveals shared pathways between inherited and sporadic forms. Research highlights key genes like LRRK2 and alpha-synuclein in disease pathogenesis.

More Related Videos

Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment
10:33

Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment

Published on: May 15, 2026

Related Experiment Videos

Last Updated: Jun 13, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment
10:33

Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment

Published on: May 15, 2026

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Parkinson's disease (PD) is often sporadic, but inherited forms offer insights into its mechanisms.
  • Mutations in specific genes (parkin, PINK1, DJ-1, LRRK2, alpha-synuclein) are linked to PD.
  • These genes are involved in crucial cellular pathways, including mitochondrial maintenance and protein aggregation.

Purpose of the Study:

  • To explore the relationship between genetic mutations in inherited Parkinson's disease and the pathogenesis of sporadic PD.
  • To identify common pathways implicated in both familial and sporadic forms of the disease.

Main Methods:

  • Review of genetic studies identifying mutations in PD-related genes.
  • Analysis of pathway involvement for genes like parkin, PINK1, DJ-1, LRRK2, and alpha-synuclein.
  • Examination of genome-wide association studies (GWAS) for risk variants in sporadic PD.

Main Results:

  • Autosomal recessive mutations in parkin, PINK1, and DJ-1 are associated with early-onset parkinsonism.
  • Dominant mutations in LRRK2 and alpha-synuclein are linked to late-onset PD with Lewy bodies.
  • Sequence variants in alpha-synuclein, LRRK2, and Tau increase susceptibility to sporadic PD.

Conclusions:

  • Understanding inherited PD pathways provides critical insights into the pathogenesis of sporadic PD.
  • Common molecular pathways are implicated in both inherited and sporadic forms of Parkinson's disease.
  • Genes like LRRK2 and alpha-synuclein are central to PD pathogenesis and represent potential therapeutic targets.